Skip to content

Perpetual Observational Study - Disease X

Perpetual Observational Study - Disease X - POS-DiseaseX

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56167
Enrollment
400
Registered
2023-11-10
Start date
2023-12-01
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

outbreaks viral infections

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: A) >18 years old B) Suspected infectious illness without a clear aetiology upon initial clinical evaluation C) Immunocompromised (Solid organ transplant recipient, OR received anti-C20 therapy in the past 9 months, OR primary immunodeficiency disorder) D) Symptom onset

Exclusion criteria

Exclusion criteria: A) Detection of a non-viral infectious agent that can explain the symptoms B) Surgery or Intensive Care admission in the last 30 days C Treatment with cytotoxic antineoplastic therapy in the last 30 days D) Symptoms of urinary tract infection

Design outcomes

Primary

MeasureTime frame
- Description of the clinical characteristics and aetiologies of infectious syndromes among the patients included in the POS; - Analysis of variations in local practices in diagnosis and treatment of Disease X among study sites;

Secondary

MeasureTime frame
- Characterization of intra-host viral evolution among immunocompromised patients with persistent viral infections; - Development of an infrastructure for prospective and systematic collection of data and clinical samples in a format that can be easily aggregated, tabulated and analysed across different participating centres;

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)